AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Marketable securities, current

KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】

Market cap
¥449.3B
P/E ratio
42.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, current (Million JPY)YoY (%)
Dec 31, 20258,300-44.19%
Dec 31, 202414,872+79.18%
Dec 31, 20238,300+0.00%
Dec 31, 20228,300-40.81%
Dec 31, 202114,022-12.83%
Dec 31, 202016,085+7.40%
Dec 31, 201914,977+80.45%
Dec 31, 20188,300+0.00%
Dec 31, 20178,300+50.91%
Dec 31, 20165,500+22.22%
Mar 31, 20164,500+0.00%
Mar 31, 20154,500

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)